Trudy L. Campbell

Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelination

M. Holcik, J. Gillard, T. Campbell, 2008, Multiple sclerosis.

Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosis

C. Ross, B. Carleton, J. Denny, 2018, Nature Genetics.

Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis

R. Marrie, J. Fisk, Tingting Zhang, 2016, Neurology.

THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES

T. Campbell, Vladimir Migounov, Stephanie J Wong, 2002 .

Effects of physical comorbidities on disability progression in multiple sclerosis

C. Wolfson, R. Marrie, J. Fisk, 2018, Neurology.

Determinants of non-adherence to disease-modifying therapies in multiple sclerosis: A cross-Canada prospective study

S. Patten, R. Marrie, J. Fisk, 2016, Multiple sclerosis.

Psychiatric comorbidity is associated with disability progression in multiple sclerosis

S. Patten, R. Marrie, J. Fisk, 2018, Neurology.

Social anxiety in a multiple sclerosis clinic population

J. Fisk, S. Kisely, V. Bhan, 2009, Multiple sclerosis.

Nursing Management of Gastrointestinal Adverse Events Associated With Delayed-Release Dimethyl Fumarate: A Global Delphi Approach

Charles Minor, T. Campbell, M. Namey, 2020, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses.